Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

Research output: Contribution to journalJournal articlepeer-review

Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.
Original languageEnglish
JournalJournal of Internal Medicine
Volume268
Issue number3
Pages (from-to)296-308
Number of pages13
ISSN0954-6820
DOIs
Publication statusPublished - 2010

ID: 33248879